These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9307472

  • 1. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
    Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, Siegel BA, Cooper JD.
    Ann Thorac Surg; 1997 Sep; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
    [Abstract] [Full Text] [Related]

  • 2. Role of positron emission tomography in staging esophageal cancer.
    Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP.
    Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
    [Abstract] [Full Text] [Related]

  • 3. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W, Schreckenberger M, Bartenstein P, Grünwald F, Oberholzer K, Junginger T.
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [Abstract] [Full Text] [Related]

  • 4. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
    Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Sundaresan SR, Patterson GA, Cooper JD.
    AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
    [Abstract] [Full Text] [Related]

  • 5. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [Abstract] [Full Text] [Related]

  • 6. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
    Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.
    Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
    [Abstract] [Full Text] [Related]

  • 7. Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.
    Yasuda S, Raja S, Hubner KF.
    Surg Today; 1995 Dec; 25(3):261-4. PubMed ID: 7640457
    [Abstract] [Full Text] [Related]

  • 8. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul 15; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 10. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, Liu QW.
    Asian Pac J Cancer Prev; 2014 Jul 15; 15(18):7719-24. PubMed ID: 25292052
    [Abstract] [Full Text] [Related]

  • 11. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
    Rankin SC, Taylor H, Cook GJ, Mason R.
    Clin Radiol; 1998 Sep 15; 53(9):659-65. PubMed ID: 9766719
    [Abstract] [Full Text] [Related]

  • 12. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
    van Westreenen HL, Heeren PA, Jager PL, van Dullemen HM, Groen H, Plukker JT.
    Ann Surg Oncol; 2003 Nov 15; 10(9):1100-5. PubMed ID: 14597450
    [Abstract] [Full Text] [Related]

  • 13. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

  • 14. Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
    Schreurs LM, Janssens AC, Groen H, Fockens P, van Dullemen HM, van Berge Henegouwen MI, Sloof GW, Pruim J, van Lanschot JJ, Steyerberg EW, Plukker JT.
    Ann Surg Oncol; 2016 Dec 15; 23(Suppl 5):1021-1028. PubMed ID: 21547703
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
    Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS, Hsieh CC, Wu YC.
    Ann Thorac Surg; 2009 May 15; 87(5):1564-8. PubMed ID: 19379906
    [Abstract] [Full Text] [Related]

  • 16. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 15; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 17. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
    Keswani RN, Early DS, Edmundowicz SA, Meyers BF, Sharma A, Govindan R, Chen J, Kohlmeier C, Azar RR.
    Gastrointest Endosc; 2009 Jun 15; 69(7):1210-7. PubMed ID: 19012886
    [Abstract] [Full Text] [Related]

  • 18. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM, Balan A, Naik K, Mirsadraee S, Scarsbrook AF.
    Clin Radiol; 2008 Jul 15; 63(7):765-73. PubMed ID: 18555034
    [Abstract] [Full Text] [Related]

  • 19. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Cancer; 2005 Jan 01; 103(1):148-56. PubMed ID: 15558794
    [Abstract] [Full Text] [Related]

  • 20. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN.
    Radiology; 1997 Jun 01; 203(3):795-800. PubMed ID: 9169707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.